USE OF TRANSGENIC MICE IN LIPOPROTEIN METABOLISM AND ATHEROSCLEROSIS RESEARCH

Citation
Lm. Havekes et al., USE OF TRANSGENIC MICE IN LIPOPROTEIN METABOLISM AND ATHEROSCLEROSIS RESEARCH, Prostaglandins, leukotrienes and essential fatty acids, 57(4-5), 1997, pp. 463-466
Citations number
6
Categorie Soggetti
Endocrynology & Metabolism",Biology
ISSN journal
09523278
Volume
57
Issue
4-5
Year of publication
1997
Pages
463 - 466
Database
ISI
SICI code
0952-3278(1997)57:4-5<463:UOTMIL>2.0.ZU;2-5
Abstract
In APoE3-Leiden transgenic mice the atherosclerotic lesion size is co rrelated with plasma cholesterol, In these mice the plasma lipid level s are positively correlated with the relative amount of APOE 3-Leiden protein on the VLDL particle. The plasma cholesterol levels are influe nced by diet, age and gender, mainly due to an effect of these factors on VLDL production rate, Excess of APOC1 protein does inhibit the hep atic clearance of VLDL remnant particles, whereas excess of apoE leads to a hampered extra-hepatic lipolysis of VLDL triglyceride.